Nkọwapụta Ụlọ ọrụ
Beijing Succeeder Technology Inc. (nke a na-akpọ SUCCEEDER), dị na Life Science Park na Beijing China, tọrọ ntọala na 2003, SUCCEEDER ọkachamara na thrombosis na hemostasis diagnostic ngwaahịa maka ahịa ụwa.
Dị ka otu n'ime ndị isi ụdị na China Diagnostic Market of Thrombosis na Hemostasis, SUCCEEDER enwetala otu R&D, Production, Marketing, Sales and Service, na-enye ndị na-enyocha coagulation na reagents, ndị na-enyocha rheology ọbara, ndị nyocha ESR na HCT, ndị na-enyocha nchịkọta platelet, yana ISO 13485, Asambodo CE na FDA edepụtara.
R&D
Dị ka otu n'ime ndị isi ụdị na China Diagnostic Market of Thrombosis na Hemostasis, SUCCEEDER enwetala otu R&D, Production, Marketing, Sales and Service, na-enye ndị na-enyocha coagulation na reagents, ndị na-enyocha rheology ọbara, ndị nyocha ESR na HCT, ndị na-enyocha nchịkọta platelet, yana ISO 13485, Asambodo CE na FDA edepụtara.
Kemgbe e guzobere ya na 2003, Succeeder etinyela aka na nyocha na mmepe, mmepụta na ire nke ngwa nnwale, reagents na consumables n'ọhịa nke thrombosis na hemostasis in vitro diagnostics, na-enye ụlọ ọrụ ọgwụ na akụrụngwa nnwale akpaaka maka coagulation ọbara, rheology ọbara. , hematocrit, nchịkọta platelet, ndị na-akwado reagents na ihe oriri.Succeeder ow bụ onye nrụpụta China na-eduga na ngalaba nyocha in vitro nke thrombosis na hemostasis.
Emebela teknụzụ isi nke Succeeder na-ekpuchi ngwa, reagents na ihe eji eri nri, yana R&D nọọrọ onwe ya pụtara ìhè yana ike imepụta teknụzụ.Ka ọ dị ugbu a, ọ nwere ụdị teknụzụ isi ise: ikpo okwu teknụzụ nyocha ọbara ọbara, ikpo okwu teknụzụ nyocha ọbara coagulation, ikpo okwu teknụzụ akụrụngwa akụrụngwa, teknụzụ isi nke reagents diagnostic coagulation, na ụzọ traceability.